# What two mouse colitis models added to the evidence

- Article ID: research-239
- Product: KPV (kpv-680)
- Canonical page: https://heritagebiolabs.com/research-library/articles/239-what-two-mouse-colitis-models-added-to-the-evidence
- Product collection: https://heritagebiolabs.com/research-library/products/kpv
- Product page: https://heritagebiolabs.com/product/kpv-680
- Reading focus: Interpreting evidence (Reading focus is a navigational tag, not an evidence grade.)
- Source years: 2008

> Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend.

Peptides are short chains of amino acids held together by peptide bonds. Some influence communication between the immune system and the tissue around it. KPV is a three-amino-acid fragment of alpha-melanocyte-stimulating hormone. An older 2008 paper compared outcomes in two models of intestinal inflammation in mice. The authors asked whether a tissue response could be seen in more than one kind of animal model. [1]

One model represented inflammation following injury to the intestinal lining. The other involved the activity of immune cells. The researchers assessed indicators including weight change and the appearance of colon tissue. They reported that animals receiving KPV showed changes consistent with lower inflammation, including fewer inflammatory changes on tissue examination. Studying both models helped them test whether the observation was limited to the particular conditions of one experiment. [1]

A change in weight provides information about the animal's overall condition. The appearance of colon tissue describes what is happening at the site of disease. An enzyme measurement associated with inflammatory cells gives another perspective. Agreement across different kinds of measurement can support a hypothesis about the model, while each measure has its own sources of variation. The value of combining them is that they describe the disease at different scales. [1]

These were animal studies of bowel inflammation. Human inflammatory bowel disease can vary in its causes, severity, duration and response to treatment. Matching some features of the illness in two models gives researchers a stronger reason to ask a clinical question. It does not show whether the peptide changes symptoms, produces remission or has an acceptable safety profile in people. [1]

## Sources

1. Klaus Kannengiesser et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory Bowel Diseases (publication 2008-03). <https://pubmed.ncbi.nlm.nih.gov/18092346/>

## Provenance

Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed. Source volume: Peptide Research Articles 048 - KPV.docx; article 239; content SHA-256 87f61dbea83ba32e3ff40865ef73e1db209685755bb49d5dcb09aa2a31ed5786.
